₹8.45
(Market cap
₹1,261 Cr
Revenue (TTM)
₹314 Cr
P/E Ratio
22.6
P/B Ratio
6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹25 Cr
-
ROE
13.9 %
-
ROCE
19.2 %
-
Industry P/E
20.16
-
EV/EBITDA
13.3
-
Debt to Equity
0.9
-
Book Value
₹120.6
-
EPS
₹17.9
-
Face value
10
-
Shares outstanding
23,328,199
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Q-Line Biotech
| -- | 7.9 | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 15.0 | 5.8 | 17.8 | 12.3 | 24.4 | 14.1 | 12.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Q-Line Biotech
|
549.1 | 1,261.1 | 313.8 | 24.5 | -- | 13.9 | 22.6 | 6.0 |
| 321.0 | 183.5 | 34.4 | -4.3 | -9.6 | -28.9 | -- | 16.3 | |
| 146.2 | 279.8 | 135.7 | 16.1 | -- | 36.8 | 54.8 | -- | |
| 277.8 | 159.3 | 45.2 | 7.2 | -- | 49.9 | 22 | 3.0 | |
| 160.0 | 220.1 | 43.1 | 6.6 | -- | 40.6 | 44.6 | 3.4 | |
| 233.2 | 222.1 | 147.0 | 2.1 | -1.2 | 1.1 | 106.7 | 1.2 | |
| 1,668.3 | 16,865.7 | 1,875.3 | 315.1 | 17.4 | 10.9 | 52.4 | 5.4 | |
| 106.2 | 203.3 | 172.9 | 11.9 | 12.7 | 9.7 | 20.1 | -- | |
| 71.0 | 116.6 | 80.0 | 1.9 | 12.2 | 4.9 | 64.4 | 2.5 | |
| 295.1 | 532.2 | 92.4 | 4.7 | -- | 4.9 | 43.3 | 5.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Q-Line Biotech
--
-
Incorporated
2010
-
Chairman
Saurabh Garg
-
Managing Director
Saurabh Garg
-
Headquarters
Lucknow, Uttar Pradesh
-
Website
Looking for more details about Q-Line Biotech Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Q-Line Biotech
What is the current share price of Q-Line Biotech Ltd Today?
The share price of Q-Line Biotech Ltd is ₹549.05 (NSE) as of 10-Jul-2026 IST. Q-Line Biotech Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Q-Line Biotech Ltd?
The P/E ratio of Q-Line Biotech Ltd is 22.63 times as on 09-Jul-2026, a 12 premium to its peers’ median range of 20.16 times.
The P/B ratio of Q-Line Biotech Ltd is 5.96 times as on 09-Jul-2026, a 161 premium to its peers’ median range of 2.28 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
What is the 52 Week High and Low of Q-Line Biotech Ltd?
The 52-week high and low of Q-Line Biotech Ltd are Rs 600.00 and Rs 431.00 as of 10-Jul-2026.
What is the market cap of Q-Line Biotech Ltd?
Q-Line Biotech Ltd has a market capitalisation of ₹ 1,261 Cr as on 09-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Q-Line Biotech Ltd?
Before investing in Q-Line Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.